A detailed history of Citigroup Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Citigroup Inc holds 2,852,612 shares of BMY stock, worth $165 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,852,612
Previous 2,839,700 0.45%
Holding current value
$165 Million
Previous $118 Million 25.18%
% of portfolio
0.09%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $512,089 - $668,196
12,912 Added 0.45%
2,852,612 $148 Million
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $13.2 Million - $17.3 Million
-326,908 Reduced 10.32%
2,839,700 $118 Million
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $14.4 Million - $16.3 Million
-299,647 Reduced 8.64%
3,166,608 $172 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $10.8 Million - $12.9 Million
-222,414 Reduced 6.03%
3,466,255 $178 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $7.39 Million - $8.27 Million
-127,716 Reduced 3.35%
3,688,669 $214 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $69 Million - $76.7 Million
-1,083,808 Reduced 22.12%
3,816,385 $244 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $100 Million - $113 Million
-1,522,465 Reduced 23.7%
4,900,193 $340 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $48.9 Million - $57.9 Million
714,035 Added 12.51%
6,422,658 $462 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $116,181 - $68.7 Million
893,704 Added 18.56%
5,708,623 $406 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $9.73 Million - $10.7 Million
-133,992 Reduced 2.71%
4,814,919 $371 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $94.3 Million - $113 Million
-1,533,513 Reduced 23.66%
4,948,911 $361 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $146 Million - $171 Million
2,727,957 Added 72.66%
6,482,424 $404 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $222 Million - $260 Million
3,754,467 New
3,754,467 $222 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.